Press Release

July 27, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C-1, Block G Dalal Street Bandra – Kurla Complex Bandra (East) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500408 NSE Symbol: TATAELXSI Dear Sirs/Madam, Sub: Press Release - “SCTIMST and Tata Elxsi Forge Strategic Partnership to Accelerate Healthcare Innovation and Medical Technology Development” Please find enclosed the Press Release dated July 27, 2026, titled “SCTIMST and Tata Elxsi Forge Strategic Partnership to Accelerate Healthcare Innovation and Medical Technology Development”. This disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The aforesaid disclosure will also be made available on the Company’s website at www.tataelxsi.com. This is for your information and records. Yours faithfully, For Tata Elxsi Limited Sneha V Company Secretary & Compliance Officer Encl.: As above SCTIMST and Tata Elxsi Forge Strategic Partnership to Accelerate Healthcare Innovation and Medical Technology Development Partnership brings together clinical expertise, biomedical research, and advanced engineering capabilities to enable next-generation healthcare solutions for India and global markets Bengaluru, India, July 27, 2026 – Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, an Institution of National Importance under the Department of Science and Technology (DST), Government of India, has signed a Memorandum of Understanding (MoU) with Tata Elxsi, a global leader in design and technology services, to collaborate on the development of next-generation healthcare solutions. The MoU was signed at SCTIMST, Thiruvananthapuram, in the presence of senior leaders from both organisations, including Dr. Sanjay Behari, Director, SCTIMST, and Manoj Raghavan, CEO & Managing Director, Tata Elxsi, along with members of the healthcare, research, and technology leadership teams from both institutions. The collaboration combines SCTIMST's strengths in cardiovascular sciences, neurosciences, biotechnology, and clinical sciences with Tata Elxsi's expertise in product engineering, design, AI, and digital technologies. Together, the organisations will address opportunities across diagnostics, medical imaging, digital health, biomedical engineering, medical devices, and related healthcare technologies for India and global markets. Unlike traditional industry-academia engagements, the partnership creates an extended innovation and engineering environment for Tata Elxsi, its customers, and healthcare partners. It brings together clinicians, specialist researchers, advanced laboratories, prototyping infrastructure, and product engineering capabilities within a single collaborative ecosystem. This will enable MedTech companies to develop, validate, and scale new products more efficiently. The partnership also strengthens capabilities in biocompatibility, toxicology, and other areas. The MoU establishes a framework for joint research, academic engagement, technology development initiatives, and intellectual property creation through project-specific collaborations. Initial efforts are expected to focus on identifying a select set of high-potential opportunities for collaborative development. Sreevatsa Sahasranaman, Senior Vice President and Head, Healthcare and Life Sciences, Tata Elxsi, said, “Healthcare innovation increasingly depends on closer collaboration between clinicians, scientists, and engineering teams. Our partnership with SCTIMST brings together complementary strengths across healthcare, technology, and product development to help address evolving healthcare needs. Recognised for its strong research and innovation capabilities, SCTIMST adds significant depth to this collaboration. We believe this partnership will help bring India-led innovation to global healthcare markets." About SCTIMST Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, is an Institution of National Importance under the Department of Science and Technology (DST), Government of India. As one of India's leading healthcare technology institutions, SCTIMST brings together a unique ecosystem comprising a Super Specialty Hospital, Biomedical Technology Wing, and Achutha Menon Centre for Health Science Studies. The institute is recognised for its contributions to healthcare technology development and its expertise in cardiovascular sciences, neurosciences, biotechnology, and public health. About Tata Elxsi Tata Elxsi is a global design and technology services company headquartered in Bangalore. It addresses the healthcare, automotive, media & telecom, consumer electronics industries. This is supported by a network of design studios, development centers, and offices worldwide. Tata Elxsi's Healthcare and Life Sciences practice is ISO 13485 certified and works with leading medical device manufacturers, pharmaceutical and biotechnology companies, healthcare providers, and digital health innovators worldwide. With capabilities spanning product engineering, design, regulatory compliance, software development, AI, cloud, and data technologies, Tata Elxsi supports customers across the product and innovation lifecycle, from concept and clinical development to commercialization and lifecycle management. For more information, visit Tata Elxsi's Healthcare and Life Sciences. Media Contact Hari Balan / Ayushi Moudgil Corporate Communications Email: media@tataelxsi.com